XEOMIN 200 V pulveris injekciju šķīduma pagatavošanai, Placebo to NT201, XEOMIN, 200 jednostek, proszek do sporządzania roztworu do wstrzykiwań
M602011072
Phase 3 small_molecule active
Quick answer
XEOMIN 200 V pulveris injekciju šķīduma pagatavošanai, Placebo to NT201, XEOMIN, 200 jednostek, proszek do sporządzania roztworu do wstrzykiwań for Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP) is a Phase 3 program (small_molecule) at Merz Pharmaceuticals GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merz Pharmaceuticals GmbH
- Indication
- Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active